CNBC's Becky Quick discusses Warren Buffett's feelings about the market.» Read More
Three points about today’s trading: 1) financials again down on weak earnings from European banks; 2) Bulls hoping that strengthening dollar would lead to a decline in commodity prices are again having a hard time; and 3) All those people arguing that the EDS/Hewlett deal would be a big challenge to IBM are missing the point.
Stocks declined Tuesday as investors juggled a mixed bag of news: Retail sales outside of the hard-hit auto sector showed suprising resilience, while a well-known analyst cut her outlook for big banks. Wal-Mart skidded after the discount giant posted decent results but issued a tepid outlook.
Hewlett-Packard has struck a deal to buy Electronic Data Systems for $12.6 billion, seeking to boost its technology services business to better compete against market leader IBM.
Stronger retail sales than expected (ex-auto up 0.5 percent, the best showing since November) has caused an 8-point pop in futures. Elsewhere: 1) Hewlett-Packard's $12.6 b deal for Electronic Data systems ($25.00 a share) is a direct challenge to IBM.
Stocks got off to a good start Monday with the Dow making triple digit gains for the week. What's the "Word on the Street?"
Stocks started the week off higher, led by financials and technology stocks. RIMM and MBIA rose, while HP declined.
Hewlett-Packard, the world's largest personal-computer maker, is close to a deal to buy technology outsourcing company Electronic Data Systems for $12 billion to $13 billion, a source told Reuters.
These stocks are well-known, they're earning money, they're reasonably priced -- and David Scott, manager of the 4-star Chase Growth Fund, thinks investors ought to own them. PLUS: Scott offered Web-only recommendations for CNBC.com readers!
As you look for your next trade, find out why you might want to stick with US based firms engaged in global growth.
Stocks closed mixed in thin trading Tuesday as the tide turned in technology's favor. Airline stocks rose as oil prices receded. Merck skidded after an FDA rejection.
Stocks pushed higher Tuesday despite concerns about interest rates ahead of the Federal Reserve's decision. Merck skidded after an FDA rejection. Airline stocks rose as oil prices receded.
Stocks declined Tuesday amid concerns about interest rates and a slide in consumer confidence. Merck dragged on the Dow industrials after the FDA rejected a key cholesterol drug.
Stocks were indicated to open slightly lower Tuesday, but big moves are unlikely until the Federal Reserve announces its decision on interest rates on Wednesday.
IBM said Tuesday it raised its quarterly cash dividend by 25 percent to 50 cents per share, lifting its payout to shareholders for the 13th year in a row.
In Monday’s Web Extra find out how Tim Seymour recommends playing oil at $120. Also get the traders' IBM play.
Earnings Season shifted into high gear, both corporate results and economic statistics were all over the proverbial map, and investors and traders found opportunities in some unlikely places.
Stocks slid Tuesday in response to disappointing earnings announcements, but that doesn’t mean investors portfolios have to take a hit. CNBC asked market experts how investors could protect their portfolios and their profits, and here are some of their suggestions.
Last month, he heard the bell ringing. Now, he sees a long road to recovery. BlackRock vice chairman and global CIO of equities Bob Doll believes there's a lot of ground to be regained.
Asian markets came under pressure on Tuesday after U.S. stocks pulled in a mixed performance. Investors sold financials following weak earnings from Bank of America.
Now that the first week of the technology earnings is over, many investors are breathing a sigh of relief.